Bank of Montreal’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-451,271
| Closed | -$19M | – | 4378 |
|
|
2023
Q2 | $19M | Buy |
451,271
+367,445
| +438% | +$14.9M | 0.01% | 762 |
|
|
2023
Q1 | $3M | Buy |
83,826
+51,426
| +159% | +$1.87M | ﹤0.01% | 1478 |
|
|
2022
Q4 | $1.19M | Buy |
32,400
+1,408
| +5% | +$55.7K | ﹤0.01% | 2087 |
|
|
2022
Q3 | $1.83K | Sell |
30,992
-50,222
| -62% | -$3.24M | ﹤0.01% | 1864 |
|
|
2022
Q2 | $5.86K | Buy |
81,214
+11,405
| +16% | +$834K | ﹤0.01% | 1331 |
|
|
2022
Q1 | $5.7M | Buy |
69,809
+24,933
| +56% | +$2.11M | ﹤0.01% | 1415 |
|
|
2021
Q4 | $4.65M | Sell |
44,876
-21,301
| -32% | -$2.05M | ﹤0.01% | 1257 |
|
|
2021
Q3 | $5.97M | Buy |
66,177
+20,896
| +46% | +$1.89M | ﹤0.01% | 1548 |
|
|
2021
Q2 | $4.06M | Buy |
45,281
+38,722
| +590% | +$3.27M | ﹤0.01% | 1705 |
|
|
2021
Q1 | $515K | Buy |
6,559
+946
| +17% | +$71.3K | ﹤0.01% | 2618 |
|
|
2020
Q4 | $415K | Buy |
5,613
+416
| +8% | +$25.9K | ﹤0.01% | 2816 |
|
|
2020
Q3 | $294K | Buy |
5,197
+425
| +9% | +$25.3K | ﹤0.01% | 2559 |
|
|
2020
Q2 | $268K | Buy |
4,772
+2,861
| +150% | +$154K | ﹤0.01% | 2580 |
|
|
2020
Q1 | $67K | Sell |
1,911
-13,760
| -88% | -$805K | ﹤0.01% | 2783 |
|
|
2019
Q4 | $932K | Buy |
15,671
+7,140
| +84% | +$384K | ﹤0.01% | 2318 |
|
|
2019
Q3 | $452K | Buy |
8,531
+767
| +10% | +$39.4K | ﹤0.01% | 2466 |
|
|
2019
Q2 | $397K | Buy |
7,764
+6,179
| +390% | +$288K | ﹤0.01% | 2555 |
|
|
2019
Q1 | $82K | Sell |
1,585
-954
| -38% | -$46.3K | ﹤0.01% | 3148 |
|
|
2018
Q4 | $99K | Buy |
2,539
+1,052
| +71% | +$48.9K | ﹤0.01% | 2954 |
|
|
2018
Q3 | $77K | Buy |
1,487
+117
| +9% | +$5.73K | ﹤0.01% | 3216 |
|
|
2018
Q2 | $65K | Buy |
1,370
+1,009
| +280% | +$41.8K | ﹤0.01% | 3315 |
|
|
2018
Q1 | $13K | Sell |
361
-2,599
| -88% | -$102K | ﹤0.01% | 3686 |
|
|
2017
Q4 | $129K | Sell |
2,960
-43,397
| -94% | -$2.03M | ﹤0.01% | 2896 |
|
|
2017
Q3 | $2.42M | Sell |
46,357
-49,480
| -52% | -$2.76M | ﹤0.01% | 1530 |
|
|
2017
Q2 | $5.61M | Buy |
95,837
+1,198
| +1% | +$62.3K | 0.01% | 1106 |
|
|
2017
Q1 | $4.34M | Sell |
94,639
-36,627
| -28% | -$1.82M | ﹤0.01% | 1136 |
|
|
2016
Q4 | $6.5M | Buy |
131,266
+38,123
| +41% | +$1.85M | 0.01% | 965 |
|
|
2016
Q3 | $4.15M | Buy |
93,143
+5,310
| +6% | +$230K | ﹤0.01% | 1171 |
|
|
2016
Q2 | $3.35M | Buy |
87,833
+5,411
| +7% | +$238K | ﹤0.01% | 1261 |
|
|
2016
Q1 | $3.4M | Buy |
82,422
+35,441
| +75% | +$1.46M | ﹤0.01% | 1178 |
|
|
2015
Q4 | $2.28M | Buy |
46,981
+13,481
| +40% | +$600K | ﹤0.01% | 1345 |
|
|
2015
Q3 | $1.34M | Buy |
+33,500
| New | +$1.46M | ﹤0.01% | 1454 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Bank of Montreal's SYNH Position: Q3 2023 in Review
Bank of Montreal sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 451,271 shares — an estimated $19M sold.
Bank of Montreal first reported a position in SYNH in Q3 2015 and held it in 32 quarters. The position peaked at $19M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Bank of Montreal reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Bank of Montreal sold 451,271 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $19M.
- Bank of Montreal first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 32 quarters.
- Bank of Montreal's Syneos Health, Inc. Class A Common Stock position peaked at $19M in Q2 2023.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.